Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, Number of Procedues & ASP by Technology, Product & Application The global radiotherapy market will witness a robust CAGR of 5.71%, valued at $6.50 billion in 2021, expected to appreciate and reach $10.71 billion by 2030, confirms Strategic Market Research. North America is the leading region, with 32.87% of the total revenue. Radiation therapy, also called radiotherapy, is a medical treatment technique that uses a suitable amount of radiation to vandalize cancer cells and reduce the size of tumors in a patient. According to an NCBI study, about 50% of cancer survivors receive radiation therapy during their treatment process, which contributes to about 40% of curative cancer treatment procedures. The doctor first consults the patient and reviews his past medical history, pathology reports, and radiology images. The patient then undergoes a physical examination to determine whether he is fit to undergo radiation therapy. The patient will then undergo a simulation process to determine the tumor’s exact location or cancer to be treated. The doctor then decides on the treatment’s different aspects, such as radiation intensity, before treating the patient’s tumor using the designed specifications. The patient then follows up on the treatment. In 1895, Wilhelm Röntgen discovered x-rays which could be used to create images of the inside of a patient’s body. In 1896, Emil Grubbe claimed to use x-rays to treat breast cancer. In 1913, William Coolidge improved the x-ray tube, which could be used to visualize deeper tumors. The invention of the ionization chamber in 1932 allowed physicians to measure the dosage of radiation delivered to the patient. In 1954, the first clinical use for proton beam-assisted radiotherapy was recorded. The 1990s introduced the stereotactic radiation therapy method using an advanced computer to treat metastatic tumors. Radiotherapy is used mainly to control the growth of cancer. It can be used to make surgery possible for people with borderline resectable cancer and locally advanced pancreatic cancer. Radiotherapy usually takes 30 minutes, which does not majorly impact a patient’s daily life. It can help to control symptoms and relieve pain for patients with advanced cancer. Key Industry Drivers - Rising Prevalence of Cancer, Technological Advancements, High Success Rate The increasing number of cancer patients globally is a major industry driver. According to the American Cancer Society, 1.9 million new cancer cases and more than 608,000 deaths were reported in 2021, an 11.7% increase in new cases and a 0.16% increase in cancer deaths from the previous two years. The industry size is expected to grow with the increasing number of cancer complaints. The increasing technological advancements help more patients access state-of-the-art equipment, which causes a boost in the radiotherapy industry. Radiotherapy like an external beam, internal, brachytherapy, targeted radionuclide, chemotherapy, immunotherapy, intrabeam, proton therapy, intensity-modulated, 3D conformal, image-guided, particle therapy, volumetric modulated arc therapy, temporally feathered, and intraoperative radiotherapy use radiopharmaceuticals and devices like gamma knife for breast cancer treatment to treat the rising occurrence of diseases like gastroenteropancreatic neuroendocrine tumors, metastatic melanoma, epithelial cancers, renal cell cancer, lung cancer, colon cancer, brain, lung, skin, esophagus, anus, and bladder cancer. According to the WCRF (World Cancer Research Fund International), there are more than 18 million cancer cases worldwide. 2.26 million people are diagnosed with breast cancer, 2.6 million with lung cancer, and 1.93 million with colon cancer. The wide range of radiotherapy applications will boost the growth of radiotherapy market. The high cure rate and the metastasis-free survival rate increases patients’ confidence in opting for radiotherapy, increasing demand for radiation therapy devices and fostering growth. According to Targeting Cancer Australia, radiotherapy had a 93.3% cure rate and a metastasis-free survival rate of 96.9% in the treatment of prostate cancer. Restraints - Lack of Healthcare Infrastructure, High costs Due to limited healthcare expenditure in emerging nations which causes the low installation of radiotherapy devices, industry growth is hindered. For example, the USA spent about USD 4.8 trillion on healthcare, while India spent about USD 34 billion. The cost of radiotherapy is high, which causes patients to look for other modes of treatment, hindering the radiotherapy market growth. According to a study, the median cost of radiation therapy per patient was USD 8600 for breast cancer, USD 9000 for lung cancer, and USD 18,000 for prostate cancer. Opportunities - Rising Healthcare Expenditure in Developing Countries Recently, more countries are increasing their expenditure in the healthcare sector to allow more people access to better facilities. This could increase the demand for radiotherapy devices which could foster growth. Market Analysis Of Different Segments Covered in the Report Based on Type External Beam Radiation Therapy Systemic Radiation therapy Internal Beam Radiation Therapy Based On Application Skin and Lip Cancer Breast Cancer Spine Cancer Prostate Cancer Lung Cancer Cervical Cancer Head & Neck Cancer By Equipment Linear Accelerators Treatment Planning Systems Radiation Therapy Simulators By End-User Hospitals Independent Radiotherapy Centres Regional Coverage Analysis North America United States Canada Mexico Rest of North America Europe Germany France Sweden Netherlands Switzerland Austria Belgium Denmark Ireland Finland United Kingdom Italy Rest of Europe Asia-Pacific China India Japan South Korea Taiwan Australia Rest of Asia-Pacific LAMEA Brazil Argentina Chile Bahrain Egypt Iran Iraq Israel Kuwait Oman Qatar Saudi Arabia United Arab Emirates Turkey Rest of LAMEA Segments Analysis & Insights After market analysis, external beam radiation therapy held the maximum revenue share by type, with 80.56%. Increased precision and accuracy of the target tumor being cured are high with external beam radiation therapy. According to Targeting Cancer Campaign data, external beam radiotherapy had an overall cure rate of 93.3% and a metastasis-free survival rate of five years with 96.9% in the treatment of prostate cancer. The breast cancer segment is poised to hold the maximum radiotherapy market share. The growing number of breast cancer cases and the growing demand for radiotherapy devices to treat breast cancer helps in the growth of the segment. According to the National Cancer Institute, the most common form of cancer is breast cancer, with more than 287,000 cases (about 15% of the total cancer cases) and more than 43,000 deaths (about 7.1% of the total cancer-related deaths) expected in 2022. The radiation therapy simulators segment is expected to have the largest global industry. Radiation therapy simulators are widely used in diagnosis, provision of medication, care planning, and patient compliance confirmation, thus boosting their market growth. The ‘hospitals’ segment is the fastest-growing industry, with a significant CAGR. The increase in cancer cases, the installation of highly advanced radiotherapy equipment, and the growing availability of funds for advanced treatment therapies helped boost the segment’s market share. According to the WCRF (World Cancer Research Fund International), around 18.1 million cancer cases were diagnosed worldwide, of which 9.3 million cases were in men and 8.8 million in women. North America is the largest global market geographically, with a revenue share of 32.87%. Increasing cancer cases and the wide availability of skilled medical professionals to treat these cases have improved the region’s market share. According to the Canadian Cancer Statistics, around 230,000 people were expected to be diagnosed with cancer, and around 85,000 would die due to the disease. Lung cancer was expected to be the most commonly diagnosed cancer, with 25%, followed by colorectal cancer (11%) and pancreatic cancer (7%). The Asia-Pacific region is expected to be the fastest-growing global radiation therapy equipment market, with a 6.82% CAGR. The increasing older population, technical advancements in radiation products, rising conferences pushing radiotherapy investments, growing cancer occurrences, and increasing radiotherapy equipment and treatment adoption will drive the segment’s growth. According to NCBI studies, around 4.8 million new cancer cases and 3.2 million cancer-related deaths are expected in China by 2022. Lung cancer is the most common cancer form in China. Lung cancer mortality is expected to rise by 40% between 2015 and 2030. Radiotherapy Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 6.50 billion The revenue forecast in 2030 USD 10.71 billion Growth rate CAGR of approximately 5.71% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By Application, By Equipment, By End-User, and By Region. By Type External Beam Radiation Therapy, Internal Beam Radiation Therapy, Systemic Radiation Therapy By Application Skin and Lip Cancer, Lung Cancer, Head & Neck Cancer, Breast Cancer, Cervical Cancer, Prostrate Cancer, Head & Neck Cancer, Spine Cancer By Equipment Radiation Therapy Simulators, Treatment Planning Systems, Linear Accelerators. By End-User Hospitals, Independent Radiotherapy Centres By Region North America, Europe, Asia Pacific, LAMEA Country Scope United States of America, United Kingdom, France, Germany, Italy, Spain, Russia, Canada, China, India, Japan, South Korea, Australia, Brazil, Argentina, Mexico, Saudi Arabia, South Africa, United Arab Emirates Company Usability Profiles Varian Medical Systems, Inc. (a subsidiary of Siemens Healthineers AG), Elekta, Accuray, Inc, Becton, GE Healthcare, Eckert & Ziegler, Hitachi Ltd., ICAD, Inc., IntraOrp Medical, Inc., Mevion Medical Systems, Inc., Panacea Medical Technologies Pvt. Ltd., ViewRay, Inc., ZEISS Group, Dickinson and Company, Ion Beam Applications SA, IsoRay Medical, Inc, P-cure Ltd. Global Radiotherapy Market Competitive Landscape Analysis The industry is highly competitive. Key leaders use strategies such as mergers & acquisitions, partnerships, and collaborations to maintain their position in the market. The radiation oncology companies that ply in this market are: Varian Medical Systems, Inc. (a subsidiary of Siemens Healthineers AG) Elekta Accuray, Inc. Ion Beam Applications SA Becton, Dickinson, and Company Eckert & Ziegler Hitachi Ltd. ICAD, Inc. IntraOrp Medical, Inc. IsoRay Medical, Inc. Mevion Medical Systems, Inc. Panacea Medical Technologies Pvt. Ltd. P-cure Ltd. ViewRay, Inc. ZEISS Group GE Healthcare Recent Developments In April 2022, Elekta and GE Healthcare announced their collaboration agreement in radiation oncology. Elekta and GE Healthcare believe that this collaboration can provide hospitals with a comprehensive offering across imaging and treatment for patients requiring radiotherapy. In February 2022, Ion Beam Applications SA (IBA) announced its partnership with the SOGAZ insurance group to install its Proteus ONE proton therapy solution in Saint-Petersburg, Russia. IBA and Sogaz believe that this partnership can help more Russian patients access radiotherapy. In December 2021, Varian Medical Systems (a Siemens Healthineers subsidiary) announced its partnership with Icon Oncology to invest in seven new linear accelerators, including Halcyon and TrueBeam radiotherapy systems, its associated software systems, skills development, and local training of Icon Oncology’s local staff and maintenance support for its machines in southern Africa. Varian and Icon Oncology believe that this partnership would increase treatment capacity and broaden patient access to healthcare in a region where cancer rates are expected to increase significantly over the next two decades. In December 2021, Accuray, Inc. announced the approval they received from the Japanese Ministry of Health, Labour, and Welfare (Shonin) to market its CyberKnife® Robotic Radiosurgery System for the treatment and cure of trigeminal neuralgia (TN) in Japan. Accuray believes that more Japanese TN patients will have access to its radiotherapy system with the Shonin approval. In October 2021, Panacea Medical Technologies announced the FDA 510 (k) clearance for its SBRT-enabled linear accelerator Siddharth-II. Panacea believes the clearance would make radiotherapy accessible and affordable for all patients. Various Devices that Key Manufacturers Develop: Product Function Key Player Probeat Series Proton Therapy. Hitachi Ltd. Siddharth II External Beam Radiation Therapy. Panacea Medical Technologies Halcyon Optimized image-guided radiotherapy. Varian Medical Systems, Inc. (a Siemens Healthineers Subsidiary) Harmony Linear acceleration of particles for radiotherapy. Elekta Radixact Image-guided; intensity-modulated radiation therapy Accuray, Inc. Frequently Asked Question About This Report How big is the radiotherapy market? The global radiotherapy market size was $6.50 billion in 2021 and is predicted to reach $10.71 billion by 2030, with a CAGR of 5.71%. What is the radiotherapy market growth? The global radiotherapy market is expected to grow at a compound annual growth rate (CAGR) of 5.71% from 2021 to 2030 to reach USD 10.71 billion by 2030. Is radiotherapy still used? Radiation therapy is still being used, with newer methods being used to cause less harm to the patient. What is the cost of radiotherapy? Currently, radiotherapy costs about USD 14,000. What is the success rate for radiation therapy? According to the MSKCC, the success rate of radiation therapy was around 90%. What are the three types of radiation treatment? The three types of radiation treatment are internal beam radiation treatment, external beam radiation treatment, and systemic radiation treatment. Which product segment is expected to garner the highest traction within the radiotherapy market? The radiation therapy stimulators segment is expected to garner the highest traction within the radiotherapy market. What are the major factors expected to limit the growth of the radiotherapy market? The major factors expected to limit the growth of the radiotherapy market are the lack of healthcare infrastructure and the high cost of radiotherapy. What is the growth rate of the Radiotherapy Market? The radiotherapy market is expected to grow at a CAGR of 5.71%. Which region has the highest growth rate in Radiotherapy Market? The Asia-Pacific region has the highest growth rate in the radiotherapy market. Which region has the largest share in Radiotherapy Market? The North American region has the largest share in the radiotherapy market. Sources https://www.cancer.gov/types/common-cancers https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298009/ https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2021.html https://www.wcrf.org/cancer-trends/worldwide-cancer-data/ https://www.targetingcancer.com.au/2015/02/radiation-therapy-95-effective-prostate-cancer/ https://www.medscape.com/viewarticle/849474 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Radiotherapy Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Radiotherapy Market 4.2.1 market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 market, by region, 2021-2030 (USD Million) 4.4 By End-User Business Analysis 4.4.1 market, By End-User, 2021-2030 (USD Million) 4.5 By Equipment Business Analysis 4.5.1 market, By Equipment, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 market, By Application, 2021-2030 (USD Million) 4.6 Type Business Analysis 4.6.1 market, By Type, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Type Analysis 5.11.1. Trends in Type (2014-2020) 5.11.2. Trends in Type (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, End-User 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By End-User Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Hospitals 7.3.1. Hospitals market, 2021-2030 (USD Million) 7.4. Independent Radiotherapy Centers market, 2021-2030 (USD Million) 7.4.1. Independent Radiotherapy Centers market, 2021-2030 (USD Million) 8. Market: By Equipment Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Linear Accelerators 8.3.1. Linear Accelerators market, 2021-2030 (USD Million) 8.4. Treatment Planning Systems 8.4.1. Treatment Planning Systems market, 2021-2030 (USD Million) 8.5. Radiation Therapy Simulators 8.5.1. Radiation Therapy Simulators market, 2021-2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Skin and Lip Cancer 9.3.1. Skin and Lip Cancer market, 2021-2030 (USD Million) 9.4. Breast Cancer 9.4.1. Breast Cancer market, 2021-2030 (USD Million) 9.5. Spine Cancer 9.5.1. Spine Cancer market, 2021-2030 (USD Million) 9.6. Prostate Cancer 9.6.1. Prostate Cancer market, 2021-2030 (USD Million) 9.7. Lung Cancer 9.7.1. Lung Cancer market, 2021-2030 (USD Million) 9.8. Cervical Cancer 9.8.1. Cervical Cancer market, 2021-2030 (USD Million) 9.9. Head & Neck Cancer 9.9.1. Head & Neck Cancer market, 2021-2030 (USD Million) 10. Market: By Type Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. External Beam Radiation Therapy 10.3.1. External Beam Radiation Therapy market, 2021-2030 (USD Million) 10.4. Systemic Radiation therapy 10.4.1. Systemic Radiation therapy market, 2021-2030 (USD Million) 10.5. Internal Beam Radiation Therapy 10.5.1. Internal Beam Radiation Therapy market, 2021-2030 (USD Million) 11. Market: Regional Outlook 11.1 North America 11.1.1. North America market, By End-User, 2021-2030 (USD Million) 11.1.2. North America market, By Equipment, 2021-2030 (USD Million) 11.1.3. North America market, by Type, 2021-2030 (USD Million) 11.1.4. North America market, by Country, 2021-2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. market, By End-User, 2021-2030 (USD Million) 11.1.4.1.2. U.S. market, By Equipment, 2021-2030 (USD Million) 11.1.4.1.3. U.S. market, by Type, 2021-2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada market, By End-User, 2021-2030 (USD Million) 11.1.4.2.2. Canada market, By Equipment, 2021-2030 (USD Million) 11.1.4.2.3. Canada market, by Type, 2021-2030 (USD Million) 11.2. Europe 11.2.1. Europe market, By End-User, 2021-2030 (USD Million) 11.2.2. Europe market, By Equipment, 2021-2030 (USD Million) 11.2.3. Europe market, by Type, 2021-2030 (USD Million) 11.2.4. Europe market, by country, 2021-2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. market, By End-User, 2021-2030 (USD Million) 11.2.4.1.2. U.K. market, By Equipment, 2021-2030 (USD Million) 11.2.4.1.3. U.K. market, by Type, 2021-2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany market, By End-User, 2021-2030 (USD Million) 11.2.4.2.2. Germany market, By Equipment, 2021-2030 (USD Million) 11.2.4.2.3. Germany market, by Type, 2021-2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France market, By End-User, 2021-2030 (USD Million) 11.2.4.3.2. France market, By Equipment, 2021-2030 (USD Million) 11.2.4.3.3. France market, by Type, 2021-2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe market, By End-User, 2021-2030 (USD Million) 11.2.4.4.2. Rest of Europe market, By Equipment, 2021-2030 (USD Million) 11.2.4.4.3. Rest of Europe market, by Type, 2021-2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific market, By End-User, 2021-2030 (USD Million) 11.3.2. Asia Pacific market, By Equipment, 2021-2030 (USD Million) 11.3.3. Asia Pacific market, by Type, 2021-2030 (USD Million) 11.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China market, By End-User, 2021-2030 (USD Million) 11.3.4.1.2. China market, By Equipment, 2021-2030 (USD Million) 11.3.4.1.3. China market, by Type, 2021-2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India market, By End-User, 2021-2030 (USD Million) 11.3.4.2.2. India market, By Equipment, 2021-2030 (USD Million) 11.3.4.2.3. India market, by Type, 2021-2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan market, By End-User, 2021-2030 (USD Million) 11.3.4.3.2. Japan market, By Equipment, 2021-2030 (USD Million) 11.3.4.3.3. Japan market, by Type, 2021-2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea market, By End-User, 2021-2030 (USD Million) 11.3.4.4.2. South Korea market, By Equipment, 2021-2030 (USD Million) 11.3.4.4.3. South Korea market, by Type, 2021-2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC market, By End-User, 2021-2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC market, By Equipment, 2021-2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC market, by Type, 2021-2030 (USD Million) 11.4. Latin America 11.4.1. Latin America market, By End-User, 2021-2030 (USD Million) 11.4.2. Latin America market, By Equipment, 2021-2030 (USD Million) 11.4.3. Latin America market, by Type, 2021-2030 (USD Million) 11.4.4. Latin America market, by country, 2021-2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil market, By End-User, 2021-2030 (USD Million) 11.4.4.1.2. Brazil market, By Equipment, 2021-2030 (USD Million) 11.4.4.1.3. Brazil market, by Type, 2021-2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico market, By End-User, 2021-2030 (USD Million) 11.4.4.2.2. Mexico market, By Equipment, 2021-2030 (USD Million) 11.4.4.2.3. Mexico market, by Type, 2021-2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America market, By End-User, 2021-2030 (USD Million) 11.4.4.3.2. Rest of the Latin America market, By Equipment, 2021-2030 (USD Million) 11.4.4.3.3. Rest of the Latin America market, by Type, 2021-2030 (USD Million) 11.5. MEA 11.5.1. MEA market, By End-User, 2021-2030 (USD Million) 11.5.2. MEA market, By Equipment, 2021-2030 (USD Million) 11.5.3. MEA market, by Type, 2021-2030 (USD Million) 11.5.4. MEA market, by Region, 2021-2030 (USD Million) 12. Competitive Landscape 12.1 Varian Medical Systems, Inc. (a subsidiary of Siemens Healthineers AG) 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. End-User Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Elekta 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. End-User Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Accuray, Inc. 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. End-User Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Ion Beam Applications SA 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. End-User Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. Becton, Dickinson and Company 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. End-User Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. Eckert & Ziegler 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. End-User Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. Hitachi Ltd 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. End-User Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. ICAD, Inc 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. End-User Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. IntraOrp Medical, Inc 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. End-User Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. IsoRay Medical, Inc 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. End-User Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. Mevion Medical Systems, Inc 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. End-User Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. Panacea Medical Technologies Pvt. Ltd. 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. End-User Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. P-cure Ltd 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. End-User Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.14. ViewRay, Inc 12.14.1. Company overview 12.14.2. Financial performance 12.14.3. End-User Portfolio Analysis 12.14.4. Business Strategy & Recent Development 12.15. ZEISS Group 12.15.1. Company overview 12.15.2. Financial performance 12.15.3. End-User Portfolio Analysis 12.15.4. Business Strategy & Recent Development 12.16. GE Healthcare 12.16.1. Company overview 12.16.2. Financial performance 12.16.3. End-User Portfolio Analysis 12.16.4. Business Strategy & Recent Development List of Tables (68 Tables) TABLE 1. MARKET, By End-User, 2021-2030 (USD Million) TABLE 2. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Independent Radiotherapy Centers, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET, By Equipment, 2021-2030 (USD Million) TABLE 5. MARKET FOR Linear Accelerators, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Treatment Planning Systems, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Radiation Therapy Simulators, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET, BY TYPE, 2021-2030 (USD Million) TABLE 9. MARKET FOR External Beam Radiation Therapy, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET FOR Systemic Radiation therapy, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Internal Beam Radiation Therapy, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET, BY Application, 2021-2030 (USD Million) TABLE 13. MARKET FOR Skin and Lip Cancer, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Breast Cancer, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Spine Cancer, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Prostate Cancer, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Lung Cancer, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Cervical Cancer, BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET FOR Head & Neck Cancer, BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, By Equipment, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA MARKET, BY TYPE, 2021-2030 (USD Million) TABLE 25. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 27. EUROPE MARKET, By Equipment, 2021-2030 (USD Million) TABLE 28. EUROPE MARKET, BY TYPE, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC MARKET, By Equipment, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC MARKET, BY TYPE, 2021-2030 (USD Million) TABLE 33. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 34. LAMEA MARKET, By End-User, 2021-2030 (USD Million) TABLE 35. LAMEA MARKET, By Application, 2021-2030 (USD Million) TABLE 36. LAMEA MARKET, BY TYPE, 2021-2030 (USD Million) TABLE 37. Varian Medical Systems, Inc. (a subsidiary of Siemens Healthineers AG): COMPANY SNAPSHOT TABLE 38. Varian Medical Systems, Inc. (a subsidiary of Siemens Healthineers AG): OPERATING SEGMENTS TABLE 39. Elekta: COMPANY SNAPSHOT TABLE 40. Elekta: OPERATING SEGMENTS TABLE 41. Accuray, Inc.: COMPANY SNAPSHOT TABLE 42. Accuray, Inc.: OPERATING SEGMENTS TABLE 43. Ion Beam Applications SA.: COMPANY SNAPSHOT TABLE 44. Ion Beam Applications SA.: OPERATING SEGMENTS TABLE 45. Becton, Dickinson and Company: COMPANY SNAPSHOT TABLE 46. Becton, Dickinson and Company: OPERATING SEGMENTS TABLE 47. Eckert & Ziegler: COMPANY SNAPSHOT TABLE 48. Eckert & Ziegler: OPERATING SEGMENTS TABLE 49. Hitachi Ltd: COMPANY SNAPSHOT TABLE 50. Hitachi Ltd: OPERATING SEGMENTS TABLE 51. ICAD, Inc: COMPANY SNAPSHOT TABLE 52. ICAD, Inc: OPERATING SEGMENTS TABLE 53. IntraOrp Medical, Inc: COMPANY SNAPSHOT TABLE 54. IntraOrp Medical, Inc: OPERATING SEGMENTS TABLE 55. IsoRay Medical, Inc: COMPANY SNAPSHOT TABLE 56. IsoRay Medical, Inc: OPERATING SEGMENTS TABLE 57. Mevion Medical Systems, Inc: COMPANY SNAPSHOT TABLE 58. Mevion Medical Systems, Inc: OPERATING SEGMENTS TABLE 59. Panacea Medical Technologies Pvt. Ltd: COMPANY SNAPSHOT TABLE 60. Panacea Medical Technologies Pvt. Ltd: OPERATING SEGMENTS TABLE 61. P-cure Ltd: COMPANY SNAPSHOT TABLE 62. P-cure Ltd: OPERATING SEGMENTS TABLE 63. ViewRay, Inc: COMPANY SNAPSHOT TABLE 64. ViewRay, Inc: OPERATING SEGMENTS TABLE 65. ZEISS Group: COMPANY SNAPSHOT TABLE 66. ZEISS Group: OPERATING SEGMENTS TABLE 67. GE Healthcare: COMPANY SNAPSHOT TABLE 68. GE Healthcare: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: End-User-Based Estimation Figure 6 Top 16 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Radiotherapy Market, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Radiotherapy Market, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Equipment, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Type, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By End-User, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 17 External Beam Radiation Therapy to Witness Higher CAGR in Market for Type Segment during Forecast Period. Figure 18 Radiation Therapy Simulators to Witness Higher CAGR in the Market for Equipment Segment during Forecast Period. Figure 19 Breast Cancer to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview